Two new studies have been in the news from our world-class leading research centre based here in Newcastle, which NECCR helps to fund.
The first is new research which means children with brain cancer may be spared gruelling chemotherapy treatment after a breakthrough by Newcastle scientists. They found children with medulloblastoma can be split into two groups for individual treatment. The scientists, led by Newcastle University, have been able to identify a chromosome signature which can tell them which children will need intensive, aggressive chemotherapy as treatment.
A new service will allow child cancer patients from all over the country to receive personalised treatment for the first time after a breakthrough by scientists from the Northern Institute for Cancer Research at Newcastle University. The therapeutic drug monitoring service allows clinicians to get vital information about how much chemotherapy individual young patients should receive.